Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lilly Gets Second Interchangeable Insulin Glargine In US
Further FDA Approval For Rezvoglar Biosimilar Adds Second Interchangeable Option
Nov 18 2022
•
By
David Wallace
Lilly’s Rezvoglar has been approved as interchangeable by the FDA • Source: Shutterstock
More from Biosimilars
More from Products